United States · Bill · HR
H.R. 6977 (118th)
Independent Drug Value Assessment Act of 2024
Introduced
11 January 2024
Last action
12 January 2024 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Nadler, Jerrold [D-NY-12], Katie Porter, Shri Thanedar
Subjects
Healthcare
Source updated
11 June 2024
Records
Official bill H.R. 6977 (118th) from United States at United States Congress. Dated 11 January 2024. Status: Referred to the Subcommittee on Health..
Timeline
11 January 2024
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
11 January 2024
Introduced
Introduced in House
Source: IntroReferral
11 January 2024
Introduced
Introduced in House
Source: IntroReferral
12 January 2024
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 11 January 2024 · Official file
Documents
2 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 11 January 2024
Introduced in House (PDF)
Introduced in House · EN · 11 January 2024
Sponsors
- Rep. Nadler, Jerrold [D-NY-12] · D · Sponsor
- Katie Porter · D · Sponsor
- Shri Thanedar · D · Cosponsor
- · hsif00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/6977
- Open data entity: https://api.congress.gov/v3/bill/118/hr/6977
- us · 118-hr-6977 · source updated 11 June 2024